Literature DB >> 32030225

Triglyceride to high-density lipoprotein cholesterol ratio as a risk factor of repeat revascularization among patients with acute coronary syndrome after first-time percutaneous coronary intervention.

Ya-Min Su1, Rui Zhang1, Rong-Feng Xu1, Hong-Lei Wang2, Hai-Hua Geng3, Min Pan3, Yang-Yang Qu1, Wen-Jie Zuo1, Zhen-Jun Ji1, Gen-Shan Ma1.   

Abstract

BACKGROUND: It is clinically important to identify high-risk patients with acute coronary syndrome (ACS) who may require repeat revascularization. This retrospective study identified risk factors for repeat revascularization among ACS patients after first-time successful percutaneous coronary interventions (PCIs). The predictive value of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio for repeat revascularization was also evaluated.
METHODS: We enrolled consecutive ACS patients who had coronary angiography performed during the period from 6 to 12 months after a first-time successful PCI. The primary outcome of the study was to identify the risk factors of repeat revascularization. The subjects were stratified based on repeat PCI events. After comparing various clinical characteristics, univariate and multivariate Cox proportional hazard model analyses were adopted to evaluate the effects of risk factors on repeat revascularization.
RESULTS: The patients (n=271) were divided into the event (+) group (n=101) and the event (-) group (n=170). In the event (+) group, target lesion revascularization (TLR) accounted for 20.79% and target vessel revascularization (TVR) accounted for 50.49% of the patients. In contrast, 52.47% of the patients required de novo vessel revascularization (DVR). After adjustment for confounding factors, the TG/HDL-C ratio [hazard ratio (HR) =1.206, 95% confidence interval (CI): 1.016-1.431, P=0.032 for each higher TG/HDL-C ratio unit] and the Gensini score (HR =1.012, 95% CI: 1.005-1.018, P<0.001 for each higher Gensini score unit) were independent risk factors for a repeat PCI. Subgroup analyses showed that higher TG/HDL-C ratios were associated with a significantly higher risk of repeat PCIs in the male, hypertensive, and diabetes mellitus subgroups.
CONCLUSIONS: The TG/HDL-C ratio and Gensini score could serve as risk factors for repeat revascularization in ACS patients after a first-time successful PCI. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Triglyceride (TG); acute coronary syndrome (ACS); high-density lipoprotein cholesterol (HDL-C); percutaneous coronary intervention (PCI); repeat revascularization

Year:  2019        PMID: 32030225      PMCID: PMC6988028          DOI: 10.21037/jtd.2019.12.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  38 in total

1.  Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.

Authors:  Milada Dobiásová
Journal:  Clin Chem       Date:  2004-07       Impact factor: 8.327

2.  Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trials.

Authors:  Maayan Konigstein; Mahesh V Madhavan; Ori Ben-Yehuda; Hussein M Rahim; Iva Srdanovic; Fotis Gkargkoulas; Ghazaleh Mehdipoor; Evan Shlofmitz; Akiko Maehara; Björn Redfors; Ankita K Gore; Thomas McAndrew; Gregg W Stone; Ziad A Ali
Journal:  Am Heart J       Date:  2019-04-12       Impact factor: 4.749

3.  Novel treatments for in-stent restenosis: sirolimus-eluting balloons enter the arena.

Authors:  Raffaele Piccolo; Tullio Niglio; Anna Franzone; Bruno Trimarco; Giovanni Esposito
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

4.  A more meaningful scoring system for determining the severity of coronary heart disease.

Authors:  G G Gensini
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

Review 5.  Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Janette Greenhalgh; Juliet Hounsome; Naqash J Sethi; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-23

Review 6.  In-stent restenosis in the drug-eluting stent era.

Authors:  George D Dangas; Bimmer E Claessen; Adriano Caixeta; Elias A Sanidas; Gary S Mintz; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

7.  Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.

Authors:  Sui-Ji Li; Zhen Ge; Jing Kan; Jun-Jie Zhang; Fei Ye; Tak W Kwan; Teguh Santoso; Song Yang; Imad Sheiban; Xue-Song Qian; Nai-Liang Tian; Tanveer S Rab; Ling Tao; Shao-Liang Chen
Journal:  JACC Cardiovasc Interv       Date:  2017-04-26       Impact factor: 11.195

8.  Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study.

Authors:  T M Hommels; R S Hermanides; S Rasoul; B Berta; A J J IJsselmuiden; G A J Jessurun; E Benit; B Pereira; G De Luca; E Kedhi
Journal:  Cardiovasc Diabetol       Date:  2019-03-09       Impact factor: 9.951

9.  High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease.

Authors:  Protasio Lemos da Luz; Desiderio Favarato; Jose Rocha Faria-Neto; Pedro Lemos; Antonio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

10.  The Relationship between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome.

Authors:  Hyun-Gyu Shin; Young-Kwang Kim; Yong-Hwan Kim; Yo-Han Jung; Hee-Cheol Kang
Journal:  Korean J Fam Med       Date:  2017-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.